Panelists discuss the current and expanding roles of genetic testing in personalizing treatment for patients with HCC. View Now >>
Kenneth Anderson, MD, explains the mechanisms of action for two new monoclonal antibodies, elotuzumab and daratumumab, currently under investigation for the treatment of multiple myeloma. View Now >>
Featured Program
Giants of Cancer Care
The OncLive News Network updates viewers on breaking news, clinical trial results, FDA approvals, and offers an inside look into leading cancer centers and clinical trials. View Now >>
Highlights from the 2014 ASH Annual Meeting
Laura Jones recaps major findings from the 2015 ASCO Annual Meeting, including phase III findings for new treatments in melanoma, chronic lymphocytic leukemia, lung cancer, breast cancer, and multiple myeloma.
View Now

Most Popular Right Now
$auto_registration$